Author
|
Age
|
Sex
|
Site of primary disease
|
TNM stage
|
Treatment of primary disease
|
Timing of PEG placement (before or after primary therapy)
|
Time from PEG placement to stomal metastasis (months)
|
Other concurrent treatment failure sites
|
Treatment of PEG-site metastasis
|
Length of survival after PEG metastasis diagnosis (months)
|
---|
Adelson[17]
|
63
|
M
|
Oropharynx
|
NA
|
Surgery
|
Before
|
6
|
Lung, liver
|
Chemo
|
4
|
Ananth[3]
|
55
|
M
|
Oral Cavity
|
T1N2aM0
|
Surgery + XRT
|
Before
|
3.5
|
NCR
|
Surgery + Chemo
|
NED
|
Balakrishnan[18]
|
50
|
M
|
Larynx
|
NA
|
Surgery
|
Before
|
NA
|
NCR
|
Surgery
|
NA
|
Becker[19]
|
49
|
M
|
Hypopharynx
|
T4N3M0
|
XRT
|
Before
|
3
|
Lung
|
Surgery
|
5
|
Bhama[20]
|
51
|
M
|
Hypopharynx
|
T2N1M0
|
XRT
|
Before
|
3.5
|
Liver, pelvis
|
Surgery
|
4
|
Bushnell[9]
|
68
|
M
|
Supraglottis
|
T4N2bM0
|
Surgery + XRT
|
After
|
14
|
Lung
|
None
|
18
|
Chatni[10]
|
53
|
F
|
Hypopharynx
|
NA
|
XRT
|
After
|
5
|
Neck
|
None
|
NA
|
Coletti[21]
|
65
|
M
|
Oral Cavity
|
T4N2cM0
|
ChemoXRT
|
Before
|
9
|
NCR
|
ChemoXRT
|
2
|
Cossentino[22]
|
62
|
M
|
Oropharynx
|
T4N2M0
|
Surgery + XRT
|
Before
|
8
|
Lung
|
None
|
2
|
|
66
|
M
|
Oropharynx
|
T3N1M0
|
XRT
|
Before
|
9
|
NA
|
None
|
NA
|
Cruz[23]
|
58
|
M
|
Oral Cavity
|
T4N0M0
|
XRT
|
Before
|
5
|
NA
|
Surgery + Chemo
|
4
|
|
48
|
M
|
Hypopharynx
|
T4N3M0
|
Surgery + ChemoXRT
|
Before
|
6
|
NA
|
Surgery
|
4
|
Daniels[24]
|
56
|
M
|
Oral Cavity
|
TxN+M0
|
Surgery + XRT
|
Before
|
3
|
NA
|
Chemo + Surgery
|
NA
|
Douglas[15]
|
45
|
M
|
Oropharynx
|
T4N3M0
|
XRT
|
Before
|
3.5
|
NCR
|
XRT
|
9
|
Hawkin[8]
|
68
|
M
|
Oropharynx
|
T3N0M0
|
XRT
|
Before
|
14
|
NCR
|
None
|
1
|
Huang[25]
|
53
|
M
|
Oropharynx
|
T4N2aM0
|
Surgery + XRT
|
Before
|
6
|
NA
|
NA
|
NA
|
Kurdow[26]
|
75
|
F
|
Hypopharynx
|
T4N0M0
|
XRT
|
Before
|
4
|
NA
|
NA
|
NA
|
Laccourreye[11]
|
65
|
M
|
Hypopharynx
|
T3N0M0
|
ChemoXRT
|
After
|
11
|
Liver
|
XRT
|
4
|
Lee[27]
|
41
|
M
|
Oropharynx
|
T4N2bM0
|
Surgery + ChemoXRT
|
Before
|
13
|
Liver, spleen
|
None
|
1
|
Lim[28]
|
51
|
M
|
Oropharynx
|
T4N1M0
|
Surgery + XRT
|
Before
|
8
|
Lung
|
Surgery
|
NA
|
Lin[13]
|
56
|
M
|
Oropharynx
|
T4N0M0
|
Surgery + XRT
|
Before
|
5
|
NCR
|
NA
|
2
|
Maccabee[29]
|
63
|
F
|
Hypopharynx
|
T4N1M0
|
ChemoXRT
|
Before
|
5
|
Primary site
|
None
|
3
|
Meurer[30]
|
45
|
M
|
Oropharynx
|
T3N1M0
|
Surgery
|
Before
|
12
|
Lung
|
ChemoXRT
|
17
|
|
76
|
F
|
Oropharynx
|
T2N0M0
|
XRT
|
Before
|
13
|
Lung
|
Surgery
|
16
|
Mincheff[4]
|
59
|
M
|
Oropharynx
|
T4N2bM0
|
Surgery + XRT
|
NA
|
4
|
NCR
|
Surgery + XRT
|
NA (Hospice)
|
Potochny[31]
|
44
|
M
|
Hypopharynx
|
T2N2M0
|
Surgery + XRT
|
Before
|
9
|
NCR
|
Surgery
|
NED
|
Preyer[14]
|
72
|
M
|
Oropharynx
|
T4N2cM0
|
ChemoXRT
|
Before
|
3
|
Lung
|
None
|
3
|
Purandare[32]
|
50
|
F
|
Oropharynx
|
T3N2M0
|
Surgery
|
NA
|
9
|
Primary site, neck
|
NA
|
NA
|
|
62
|
M
|
Oral Cavity
|
T2N0M0
|
Surgery
|
NA
|
15
|
Primary site
|
NA
|
NA
|
Schiano[12]
|
43
|
M
|
Hypopharynx
|
T4NxM0
|
Chemo
|
After
|
4
|
Primary site, neck
|
NA
|
NA
|
Schneider[33]
|
61
|
F
|
Oropharynx
|
T4N0M0
|
Surgery + XRT
|
Before
|
10
|
NCR
|
Surgery
|
NED
|
Sharma[34]
|
40
|
M
|
Oral Cavity
|
T4N3M0
|
ChemoXRT
|
Before
|
6
|
Primary site
|
Surgery + Chemo
|
NA (Hospice)
|
Siddiqi[35]
|
56
|
F
|
Supraglottis
|
T3N2bM0
|
ChemoXRT
|
Before
|
7
|
NA
|
NA
|
2
|
Sinclair[36]
|
61
|
M
|
Oropharynx
|
T2N1M0
|
XRT
|
Before
|
5
|
Left axilla
|
Surgery + ChemoXRT
|
NA (recurrent disease detected)
|
Thakore[37]
|
50
|
M
|
Larynx
|
NA
|
Surgery + ChemoXRT
|
NA
|
NA
|
Lung, hip, brain
|
ChemoXRT
|
6
|
Thorburn[38]
|
56
|
M
|
Supraglottis
|
T4N3M0
|
XRT
|
Before
|
11
|
NA
|
NA
|
1
|
Tucker[16]
|
NA
|
NA
|
Hypopharynx
|
NA
|
ChemoXRT
|
Before
|
3
|
NA
|
NA
|
NA
|
Van erpecum[39]
|
69
|
M
|
Hypopharynx
|
T4N0M0
|
XRT
|
Before
|
10
|
NCR
|
XRT + Surgery
|
1
|
Current series
|
69
|
M
|
Hypopharynx
|
T2N2aM0
|
ChemoXRT
|
Before
|
22
|
Adrenals, liver, lung
|
Chemo XRT
|
8
|
|
77
|
M
|
Supraglottis
|
T3N1M0
|
ChemoXRT
|
Before
|
16
|
NCR
|
Chemo
|
5
|
|
46
|
M
|
Oral Cavity
|
T4N1M0
|
ChemoXRT
|
Before
|
8
|
NCR
|
Surgery
|
19
|
|
64
|
M
|
Oropharynx
|
T1N2cM0
|
XRT
|
Before
|
7
|
Primary site, neck
|
Surgery
|
NED
|
Total cases
|
42
| | | | | | | | | |
- Abbreviations: NA, not available; Chemo, Chemotherapy; XRT, radiation therapy; NCR, no concurrent recurrence; NED, no evidence of disease.